- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 39.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 42.93M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 38.69M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $233M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $167M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $39M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $38M |
| Capex | Q1 2026 · Mar 31, 2026 | $427M |
| Capex | Q1 2026 · Mar 31, 2025 | $514M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $583M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $651M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $182M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $198M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.86B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.05B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.12B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.67B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.78B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.37B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.34B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.49B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.47B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.23B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.39B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.33 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.36 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.32 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $380M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $368M |
| Net Income | Q1 2026 · Mar 31, 2026 | $93M |
| Net Income | Q1 2026 · Mar 31, 2025 | $98M |